Walmart went from a single store in 1962 to more than 11500 stores in 27 countries with 510 bn $ in sales in 2019
Dmart has 214 stores as of March 20 ,whole India to cover,good management, long runway,steep valuations @DMartSupport#DMart@Walmart@Flipkart#India@CNBC@ET_RISE
Avenue Supermart
Difficult quarter ,Eps for q1fy21 0.62 compared to 5.18 q1fy20
PAT June,20 40.09cr / Jun19 323.09 cr
Revenue fell 33.2% #COVID19 ,lockdowns,restricted store timings,wavering policies,sales of only essential goods in certain places affected sales @DMartSupport
Customers preferred local kirana shops post opening,home delivery
Footfalls extremely low in April,May recovery seen in June
Dmart ready App started for home delivery during lockdown,stopped once stores allowed to start,management should continue this segment seein Amazon,Flipkt
Dmart focuses on essential goods sales,value prices,limited business allowed company to take care of quarter expenses
Certain cases, lower cases,routine business has returned to precovid level
Added 2 new stores
Future guidance uncertain @ITCCorpCom@HUL_News@Nestle@DaburIndia
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Laurus Synthesis Private Limited ,CDMO subsidiary signed multi-year contract with global life science company in Q2 ,entails complete drug development & mfng portfolio niche APIs
Evolving China issues - impact API prices,RM,logistics
#lauruslabs
No's in line
Rev 1411.9 vs 839.1 cr yoy
EBIDTA 450.3 vs 191.8 Cr
EBITDA Margin 31.9% vs 22.9% yoy
PAT 296.9 vs 110.2 Cr yoy EPS 5.53 vs 2.06
Fy21 /20
Rev 4837 vs 2837
PAT 317 vs 38
EPS 18.36 vs 4.79 #Q4updates🐝
Generic API division robust growth 61% YoY
Anti Viral growth of 70% YoY
Generic FDF Rev up 102% YoY
Growth led by higher LMIC mkt vols & increased
vols from US & EU
Custom Synthesis division recorded a strong growth of 35% YoY
Generic API Division
Strong demand 1st line ARV API
Robust order book ,adding more capacity to meet demand
Other APIs (CVS , DM) good growth
Discussion with Generic Partners for CM opportunity
Dedicated block for Non-ARV APIs, expansion of
High Potent capacity at Unit 4
#subex#Q3marketupdates#Q3concall#Q3updates
Concall transcript Q3fy21
Rev 93.9 cr ,Ebidta 20.3 cr & PAT 8.5 cr
9mfy21 Rev 275.9 cr up 6% yoy
Interim dividend of 10%
Moved into new corporate office in Bengaluru
In IoT focus on mftng sector,secured 4 new customers in Q3
ID central (identity analytics solution) launched in Indonesia, 1st customer onboard
NGP platform, next gen platform to revolutionize way telcos operate in OSS & BSS system ,cloud native API based application
Expect more 5g contracts in APAC & ME in coming quarters
Vision to emerge as a leader in digital trust solutions in multi vertical environment
Closed about $28.5mn deals in 9mfy21 ,Q4 to exceed Q3 in deal wins
Tech mahindra partnership around Block chain area
New product offering for Telcos- Augmented Analytics platform
Vols Q3fy21/20
Performance surfactants 36618/34978
Speciality 21620/19295
Total 58238/54273
Revenue HLs
Q3fy21/20 in crs
Performance surfactants 401/387
Speciality 277/242
Total 678/629
PAT 85/48
9mnths fy21 vols
India mkt up 13.3%
Africa & ME Up 6.3%
ROW down -10.1%
9mnth FHs in cr
PS 1292/1187
Speciality 717/759
Total 2009/1946
PAT 223/168
Truly Indian MNC
:Leading mftr of ingredients for home & personal care industry
:preferred supplier for MNC,Regional & local Fmcg
:205+ product grades
: 7 strategic facilities (5 India,1Egypt ,1 US)
: Extensive R&D capacity
: intellectual property- 78 approved,1e applied